Serum AST and ALT activities have the advantage of low cost and availability for detection of liver injury, establishing their measurement as important biomarkers in identifying the presence of liver fibrosis in T2D patients with NAFLD. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.